Novel Anticancer Triple Formula Based on Aptamer-Conjugated PEGylated Nanoliposomes
Background Cancer remains a leading cause of death worldwide, necessitating the development of affordable and innovative therapies to reduce its human and economic burden. Objectives In this study, we aimed to develop a synergistic anticancer formula encapsulated in nanoliposomes to enhance efficacy...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-07-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338251356548 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!